Cardiovascular & Circulatory
Vascular, natriuretic and circulatory peptides studied in cardiovascular and endothelial research. 9 profiles
Albumin-Binding Peptide Analogs
Category of peptides described as engineered to bind serum albumin for a longer half-life; specific products are undefined in the literature.
Read profile →02Angiopoietin Peptide Analogs
Vendor umbrella for peptides marketed as angiopoietin analogs; individual sequences and functions are undocumented.
Read profile →03Atrial Natriuretic Peptide (ANP) Analogs
Marketed peptides classed as analogs of atrial natriuretic peptide; sequences are undisclosed and no published characterization exists.
Read profile →04Cardiogen (Khavinson Cardiac Bioregulator)
Marketed short-peptide cardiac bioregulator in the Khavinson tradition; product identity and supporting studies could not be confirmed.
Read profile →05Endothelin Receptor Peptide Analogs
Catalog name implying peptide modulators of endothelin receptors; not a recognized class, and products are undocumented.
Read profile →06Heparin-Binding Peptide Analogs
Generic catalog heading for peptides grouped by heparin-binding activity; no single defined product with published identity.
Read profile →07Nattokinase
Fibrinolytic serine protease enzyme from fermented soybeans (natto); studied as an oral supplement for blood-flow support.
Read profile →08VEGF Peptide Fragments
VEGF-derived peptides are studied in angiogenesis research, but this generic fragments category names no disclosed product.
Read profile →09VIP (Vasoactive Intestinal Peptide)
A 28-amino-acid neuropeptide with vasodilatory, inotropic, and broad anti-inflammatory actions across cardiovascular and immune systems.
Read profile →